Yixintang Pharmaceutical Group Co., Ltd. Operating Cash Flow for the year ending December 31, 2024: USD 235.65 M

Yixintang Pharmaceutical Group Co., Ltd. Operating Cash Flow is USD 235.65 M for the year ending December 31, 2024, a -20.91% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Yixintang Pharmaceutical Group Co., Ltd. Operating Cash Flow for the year ending December 31, 2023 was USD 297.95 M, a -17.66% change year over year.
  • Yixintang Pharmaceutical Group Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 361.85 M, a 28.33% change year over year.
  • Yixintang Pharmaceutical Group Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 281.97 M, a 78.11% change year over year.
  • Yixintang Pharmaceutical Group Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 158.31 M, a 12.16% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities